[The production of erythrogenic toxin and the epidemic process in respiratory streptococcal infection]. 1995

N I Briko, and V V Zhukov, and L O Dynga, and A S Eshchina, and H Knol, and D Gerlach, and W Keller, and V D Beliakov

The capacity of Streptococcus pyogenes, isolated from clinically healthy children in a large organized group, for producing erythrogenic toxin A, B and C was studied. The dynamics of toxin production was compared with changes in the levels of morbidity and carrier state, as well as with some characteristics of the interaction between the populations of the infective agent and the host by such values as virulence and susceptibility. Similarity in the dynamics of the parameters under study was noted. The seasonal dynamics of characteristics which determined the capacity for toxin production significantly influenced the levels and one year morbidity dynamics with respiratory streptococcal infection. The study demonstrated the information value of the characteristics of toxin production for understanding both the interval mechanisms of the epidemic process and the influence of the external ones on subsequent epidemic situation.

UI MeSH Term Description Entries
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D002165 Camping Living outdoors as a recreational activity.
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004196 Disease Outbreaks Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS. Outbreaks,Infectious Disease Outbreaks,Disease Outbreak,Disease Outbreak, Infectious,Disease Outbreaks, Infectious,Infectious Disease Outbreak,Outbreak, Disease,Outbreak, Infectious Disease,Outbreaks, Disease,Outbreaks, Infectious Disease
D005098 Exotoxins Toxins produced, especially by bacterial or fungal cells, and released into the culture medium or environment. Exotoxin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

N I Briko, and V V Zhukov, and L O Dynga, and A S Eshchina, and H Knol, and D Gerlach, and W Keller, and V D Beliakov
January 1988, Methods in enzymology,
N I Briko, and V V Zhukov, and L O Dynga, and A S Eshchina, and H Knol, and D Gerlach, and W Keller, and V D Beliakov
June 1968, Annales de l'Institut Pasteur,
N I Briko, and V V Zhukov, and L O Dynga, and A S Eshchina, and H Knol, and D Gerlach, and W Keller, and V D Beliakov
August 1987, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology,
N I Briko, and V V Zhukov, and L O Dynga, and A S Eshchina, and H Knol, and D Gerlach, and W Keller, and V D Beliakov
May 1997, Infection and immunity,
N I Briko, and V V Zhukov, and L O Dynga, and A S Eshchina, and H Knol, and D Gerlach, and W Keller, and V D Beliakov
March 1977, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
N I Briko, and V V Zhukov, and L O Dynga, and A S Eshchina, and H Knol, and D Gerlach, and W Keller, and V D Beliakov
January 1980, Pharmacology & therapeutics,
N I Briko, and V V Zhukov, and L O Dynga, and A S Eshchina, and H Knol, and D Gerlach, and W Keller, and V D Beliakov
August 1973, Annales d'immunologie,
N I Briko, and V V Zhukov, and L O Dynga, and A S Eshchina, and H Knol, and D Gerlach, and W Keller, and V D Beliakov
March 2001, Kidney international,
N I Briko, and V V Zhukov, and L O Dynga, and A S Eshchina, and H Knol, and D Gerlach, and W Keller, and V D Beliakov
January 1997, Advances in experimental medicine and biology,
N I Briko, and V V Zhukov, and L O Dynga, and A S Eshchina, and H Knol, and D Gerlach, and W Keller, and V D Beliakov
January 1982, Trudy Instituta imeni Pastera,
Copied contents to your clipboard!